C-3-G mitigates ischemia-reperfusion-induced oxidative stress and tissue injury by targeting Nox4 and modulating the Nrf2-Keap1-HO-1 antioxidant axis, supporting its potential as an adjunct therapy in the acute phase of ischemic stroke.
Li et al. (Thu,) studied this question.